{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:28:19Z","timestamp":1767706099838},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,6,17]],"date-time":"2010-06-17T00:00:00Z","timestamp":1276732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,6,17]],"date-time":"2010-06-17T00:00:00Z","timestamp":1276732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s15010-010-0035-y","type":"journal-article","created":{"date-parts":[[2010,6,16]],"date-time":"2010-06-16T06:42:40Z","timestamp":1276670560000},"page":"381-385","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: evaluation of risk factors"],"prefix":"10.1007","volume":"38","author":[{"given":"C.","family":"Reinheimer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Allwinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. W.","family":"Doerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wittek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,17]]},"reference":[{"key":"35_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/beha.1999.0071","volume":"13","author":"KE Brown","year":"2000","unstructured":"Brown KE. Haematological consequences of parvovirus B19 infection. Baillieres Best Pract Res Clin Haematol. 2000;13:245\u201359.","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"key":"35_CR2","doi-asserted-by":"publisher","unstructured":"Yu MY et al. Parvovirus B19 transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples. Transfusion. 2010. doi:10.1111\/j.1537-2995.2010.02591.x.","DOI":"10.1111\/j.1537-2995.2010.02591.x"},{"key":"35_CR3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/BF02722595","volume":"68","author":"N Choudhury","year":"2010","unstructured":"Choudhury N, Adke S. Transfusion transmitted diseases. Indian J Pediatr. 2010;68:951\u20138.","journal-title":"Indian J Pediatr"},{"key":"35_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1375\/twin.12.2.175","volume":"12","author":"M Schiesser","year":"2009","unstructured":"Schiesser M, et al. Discordant outcomes in a case of parvovirus b19 transmission into both dichorionic twins. Twin Res Hum Genet. 2009;12:175\u20139.","journal-title":"Twin Res Hum Genet"},{"key":"35_CR5","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1128\/JCM.42.5.2013-2019.2004","volume":"42","author":"K Hokynar","year":"2004","unstructured":"Hokynar K, et al. Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol. 2004;42:2013\u20139.","journal-title":"J Clin Microbiol"},{"key":"35_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/10245330600954171","volume":"11","author":"P Sharma","year":"2006","unstructured":"Sharma P, et al. Parvovirus B-19 induced acute red cell aplasia in patients with chronic lymphocytic leukemia and neurofibromatosis type-1. Hematology. 2006;11:257\u20139.","journal-title":"Hematology"},{"key":"35_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cca.2006.04.018","volume":"372","author":"D Peterlana","year":"2006","unstructured":"Peterlana D, et al. Serologic, molecular detection of human Parvovirus B19 infection. Clin Chim Acta. 2006;372:14\u201323.","journal-title":"Clin Chim Acta"},{"key":"35_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ejim.2007.09.013","volume":"19","author":"S Aslanidis","year":"2008","unstructured":"Aslanidis S, et al. Parvovirus B19 infection, systemic lupus erythematodes activation of an aberrant pathway? Eur J Intern Med. 2008;19:314\u20138.","journal-title":"Eur J Intern Med"},{"key":"35_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12098-009-0057-6","volume":"76","author":"CK Sasidharan","year":"2009","unstructured":"Sasidharan CK, et al. Red baby syndrome a new disease due to parvovirus B-19 observed in Kerala. Indian J Pediatr. 2009;76:309\u201312.","journal-title":"Indian J Pediatr"},{"key":"35_CR10","unstructured":"Modrow S. Kapitel Parvovirus in Doerr HW, Gerlich WH, Medizinische Virologie, 2. Aufl. 2010. Stuttgart: Thieme."},{"key":"35_CR11","first-page":"373","volume":"75","author":"JT Servey","year":"2007","unstructured":"Servey JT, et al. Clinical presentations of parvovirus B19 infection. Am Fam Physician. 2007;75:373\u20136.","journal-title":"Am Fam Physician"},{"key":"35_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1128\/JCM.01672-08","volume":"47","author":"T Schenk","year":"2009","unstructured":"Schenk T, et al. High prevalence of human Parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol. 2009;47:106\u201310.","journal-title":"J Clin Microbiol"},{"key":"35_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/ar2480","volume":"10","author":"D Vassilopoulos","year":"2008","unstructured":"Vassilopoulos D, et al. Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res Ther. 2008;10:215.","journal-title":"Arthritis Res Ther"},{"key":"35_CR14","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1186\/ar2281","volume":"9","author":"B Weissbrich","year":"2007","unstructured":"Weissbrich B, et al. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis. Arthritis Res Ther. 2007;9:R82.","journal-title":"Arthritis Res Ther"},{"key":"35_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jcv.2004.11.011","volume":"33","author":"A Lundqvist","year":"2005","unstructured":"Lundqvist A, et al. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients. J Clin Virol. 2005;33:71\u20134.","journal-title":"J Clin Virol"},{"key":"35_CR16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1046\/j.1365-2141.1999.01241.x","volume":"104","author":"F Forestier","year":"1999","unstructured":"Forestier F, et al. Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis. Br J Haematol. 1999;104:925\u20137.","journal-title":"Br J Haematol"},{"key":"35_CR17","doi-asserted-by":"crossref","unstructured":"Kessler CM. New perspectives in hemophilia treatment. Hematology Am Soc Hematol Educ Program. 2005:429\u201335.","DOI":"10.1182\/asheducation-2005.1.429"},{"key":"35_CR18","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/cncr.24107","volume":"115","author":"L Sung","year":"2009","unstructured":"Sung L, et al. Infections and associations with different intensity of chemotherapy in children with acute myeloid leukemia. Cancer. 2009;115:1100\u20138.","journal-title":"Cancer"},{"key":"35_CR19","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/sj.bjc.6604094","volume":"97","author":"M Debled","year":"2007","unstructured":"Debled M, et al. Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis. Br J Cancer. 2007;97:1642\u20137.","journal-title":"Br J Cancer"},{"key":"35_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1471-2334-7-137","volume":"7","author":"KSR Massaro","year":"2007","unstructured":"Massaro KSR, et al. Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis. 2007;7:137.","journal-title":"BMC Infect Dis"},{"key":"35_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2407-4-22","volume":"4","author":"BV Fortner","year":"2004","unstructured":"Fortner BV, et al. Medical visits for chemotherapy and chemotherapy-induced neutropenia: a survey of the impact on patient time and activities. BMC Cancer. 2004;4:22.","journal-title":"BMC Cancer"},{"key":"35_CR22","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1017\/S0950268807009958","volume":"136","author":"C R\u00f6hrer","year":"2008","unstructured":"R\u00f6hrer C, et al. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect. 2008;136:1564\u201375.","journal-title":"Epidemiol Infect"},{"key":"35_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1017\/S095026880600731X","volume":"135","author":"M Enders","year":"2007","unstructured":"Enders M. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect. 2007;135:563\u20139.","journal-title":"Epidemiol Infect"},{"key":"35_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1017\/S0950268804002389","volume":"132","author":"E Manaresi","year":"2004","unstructured":"Manaresi E, et al. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus b19 in Italian blood donors. Epidemiol Infect. 2004;132:857\u201362.","journal-title":"Epidemiol Infect"},{"key":"35_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1099\/00222615-25-2-151","volume":"25","author":"BJ Cohen","year":"1988","unstructured":"Cohen BJ. The prevalence of antibody to human parvovirus B 19 in England and Wales. J Med Microbiol. 1988;25:151\u20133.","journal-title":"J Med Microbiol"},{"key":"35_CR26","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1128\/JCM.40.3.933-936.2002","volume":"40","author":"ED Heegaard","year":"2002","unstructured":"Heegaard ED, et al. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals. J Clin Microbiol. 2002;40:933\u20136.","journal-title":"J Clin Microbiol"},{"key":"35_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1017\/S0950268800068552","volume":"113","author":"Y Matsunaga","year":"1994","unstructured":"Matsunaga Y, et al. Low prevalence of antibody to human parvovirus B19 in Singapore. Epidemiol Infect. 1994;113:537\u201340.","journal-title":"Epidemiol Infect"},{"key":"35_CR28","unstructured":"Richtlinien des Bundesausschusses der \u00c4rzte und Krankenkassen \u00fcber die \u00e4rztliche Betreuung w\u00e4hrend der Schwangerschaft und nach der Entbindung (\u201cMutterschafts-Richtlinien\u201d) in der Fassung vom 10. Dezember 1985 (ver\u00f6ffentlicht im Bundesanzeiger Nr. 60 a vom 27. M\u00e4rz 1986) zuletzt ge\u00e4ndert am 6. August 2009, ver\u00f6ffentlicht im Bundesanzeiger 2009, Nr. 174: S. 3 921 in Kraft getreten am 19. November 2009."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-010-0035-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-010-0035-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-010-0035-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-010-0035-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:09:14Z","timestamp":1659096554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-010-0035-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,17]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1007\/s15010-010-0035-y","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,17]]},"assertion":[{"value":"18 March 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}